Diana Melo, MD
Interventional Cardiology · Salt Lake City, UTNPI 1295269322
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Abbott at 46.7% of the total. 2025 is the largest year on record at $2,534, more than ten times the $18 reported in 2022. That places this record below the midpoint for interventional cardiology clinicians in UT, where the typical reported total is $5,946.
Across 26 payments — averaging $167.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$2K
- Shockwave Medical, Inc$413
- Chiesi USA, Inc.$96
- Cathworks, Inc.$84
- W. L. Gore & Associates, Inc.$50
- plus $149 from 4 others
What the payments were for
- Travel & lodging$2,49557%
- Food & beverage$1,81542%
- Education$501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 9 | $2,037 |
| Boston Scientific | 6 | $1,531 |
| Shockwave Medical, Inc | 2 | $413 |
| Chiesi USA, Inc. | 2 | $96 |
| Cathworks, Inc. | 1 | $84 |
| W. L. Gore & Associates, Inc. | 1 | $50 |
| Penumbra, Inc. | 1 | $48 |
| Edwards Lifesciences | 2 | $41 |
| Medtronic | 1 | $36 |
| Canon Medical Systems USA, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,359 in reported general payments places this provider in the 45th percentile of 45 interventional cardiology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 43 | $546 |
| Atorvastatin Calcium | 26 | $308 |
| Metoprolol Succinate | 12 | $135 |
| Losartan Potassium | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Salt Lake City
- Vamsee YagantiSalt Lake City$390K
- Anwar TandarSalt Lake City$131K
- Stavros DrakosSalt Lake City$79K
- Frederick WeltSalt Lake City$26K
- Scott HackingSalt Lake City$22K
- Eric LindleySalt Lake City$18K
- Lee LinstrothSalt Lake City$14K
- Theophilus OwanSalt Lake City$9K
- Tara JonesSalt Lake City$4K
- Scott BrewsterSalt Lake City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.